INCR,InterCure Ltd. | Healthcare

Healthcare

INCR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

InterCure Ltd.INCR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector.

The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Latest News >

Stantec Q2 Adjusted Profit Rises 8.6% on Revenue Gains

Aug 7, 2024

05:09 PM EDT, 08/07/2024 (MT Newswires) -- Stantec ( STN ) on Wednesday said its second-quarter adjusted profit rose 8.6% on higher revenue. The engineering and design company said its adjusted profit, excluding most one-time items, rose to $127.2 million, or $1.12 per share, in the period, up from $109.43 million, or $0.99 in the year-prior quarter. Revenue rose 17%...

Dolby Laboratories Fiscal Q3 Non-GAAP EPS Increases, Revenue Falls; Issues Q4 Outlook

Aug 7, 2024

05:07 PM EDT, 08/07/2024 (MT Newswires) -- Dolby Laboratories ( DLB ) reported fiscal Q3 non-GAAP earnings Wednesday of $0.71 per diluted share, up from $0.55 a year earlier. Three analysts polled by Capital IQ expected $0.59. Revenue for the quarter ended June 28 was $288.8 million, down from $298.4 million a year earlier. Analysts expected EPS of $286.2 million....

U-Haul Fiscal Q1 Earnings Fall, Revenue Rises -- Shares Down After Hours

Aug 7, 2024

05:07 PM EDT, 08/07/2024 (MT Newswires) -- U-Haul (UHAL) reported fiscal Q1 earnings late Wednesday of $0.95 per diluted share, down from $1.27 per share a year earlier. One analyst polled by Capital IQ expected $1.20. Revenue for the quarter ended June 30 was $1.55 billion up from $1.54 billion a year earlier. A single analyst surveyed by Capital IQ...

Curtiss-Wright Q2 Adjusted Earnings, Sales Rise; Raises 2024 Guidance

Aug 7, 2024

05:07 PM EDT, 08/07/2024 (MT Newswires) -- Curtiss-Wright ( CW ) reported Q2 adjusted earnings late Wednesday of $2.67 per diluted share, up from $2.15 a year earlier. Analysts polled by Capital IQ expected $2.29. Net sales for the quarter ended June 30 rose to $784.8 million from $704.4 million a year earlier. Analysts surveyed by Capital IQ expected $735.8...